A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the Knee

Clinical trial NCT00131352 · COMPLETED

Trial details

NCT number: NCT00131352
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoarthritis, Knee Musculoskeletal Diseases

Start date: 2005-05-01
Primary completion: 2006-09-01
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.